PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
The Biomedical Division of PHC Corporation (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has received a 2024 Innovation Award from The Analytical Scientist1 for its live cell metabolic analyzer, LiCellMoTM. LiCellMo, launched for research use in Japan in September and the United States, UK, EU, China and other Asian select geographies in October2, provides continuously measured data on key cellular metabolic pathways3, giving researchers a precise picture of previously unobservable changes in the state of cells over time and allowing them to make more informed research decisions. This will help contribute to novel research findings and important advances in therapies. It is designed to reveal cellular metabolic mechanisms and improve the reproducibility and quality of cell cultures in the development of manufacturing processes for cell and gene therapy products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211103952/en/
*For research purposes only. (Graphic: Business Wire)
The Analytical Scientist focuses on the people, technology and innovations shaping measurement science. The publication issues its annual Innovation Awards to recognize technical advances that are positioned to open doors in analytical sciences.
In research for new cell and gene therapies (CGT), it is essential to assess the state of cells and create an optimal cell culture environment. LiCellMo allows researchers to visualize metabolic changes in cell cultures in real time, providing a more complete picture of cell activity for research uses in CGT. Instead of requiring researchers to take periodic samples of the culture medium for evaluating cell metabolism, which can make it difficult to monitor changes in cell conditions over time and carries the risk of contamination, LiCellMo provides minute-by-minute measurements of glucose and lactate levels in the culture medium. LiCellMo can be easily installed in a laboratory’s existing compatible CO2 incubator with no change to the usual culture environment. It offers researchers a flexible solution to challenges faced in conventional cell culture methods.
PHC Corporation is a subsidiary of PHC Holdings Corporation (TOKYO: 6523), a global collection of healthcare companies referred to collectively as PHC Group. The in-line monitoring technology4 featured in LiCellMo builds on proprietary technology from a blood glucose monitoring sensor developed by another part of PHC Corporation, the In Vitro Diagnostics (IVD) Division.
Chikara Takauo, Director of PHC Corporation and Head of the Biomedical Division, said, “We believe LiCellMo will give researchers the opportunity to gain unprecedented new knowledge on cell metabolism, especially in the fields of cancer immunology and stem cell research, and advance the manufacturing process for new treatments in those fields. This award is a recognition of both the immediate contribution of LiCellMo in research laboratories and of its promise for supporting the development of future therapies.”
1theanalyticalscientist.com/techniques-tools/the-analytical-scientist-innovation-awards-2024-10
2www.phchd.com/global/phc/news/2024/0904
3 A series of biochemical reactions within cultured cells that produce the energy required for cellular functions and survival.
4 A technology that enables continuous measurement of cellular metabolites in culture medium without the need for sampling, achieved by maintaining constant immersion in the medium.
About the Biomedical Division of PHC Corporation
Established in 1969, PHC Corporation is a Japanese subsidiary of PHC Holdings Corporation (TOKYO: 6523), a global healthcare company that develops, manufactures, sells, and services solutions across diabetes management, healthcare solutions, life sciences and diagnostics. The Biomedical Division supports the life sciences industry helping researchers and healthcare providers in around 110 countries and regions through its PHCbi-branded laboratory and equipment and services including CO2 incubators and ultra-low temperature freezers.
www.phchd.com/global/phc
About PHC Holdings Corporation (PHC Group)
PHC Holdings Corporation (TOKYO: 6523) is a global healthcare company with a mission of contributing to the health of society through healthcare solutions that have a positive impact and improve the lives of people. Its subsidiaries (referred to collectively as PHC Group) include PHC Corporation, Epredia, Ascensia Diabetes Care, LSI Medience Corporation, Mediford, and Wemex. Together, these companies develop, manufacture, sell and service solutions across diabetes management, healthcare solutions, life sciences and diagnostics. PHC Group’s consolidated net sales in FY2023 were JPY 353.9 billion with global distribution of products and services in more than 125 countries.
www.phchd.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241211103952/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Computershare to Acquire ingage IR Limited12.12.2024 10:31:00 CET | Press release
Computershare Limited (ASX: CPU) has announced that it has agreed to acquire ingage IR Limited. ingage provides investor relations and engagement software to help listed companies around the world build and manage their investor relations function. The company has clients in 15 countries globally and was included in the FT1000 ranking of Europe’s fastest-growing companies in 2023 and 2024. Fiona Chalmers, global Head of Issuer Services at Computershare, said: “Shareholder connectivity is increasing in its strategic importance for our clients, and it’s critical that companies maintain a first-rate Investor Relations function in a rapidly changing landscape. “Acquiring ingage is an important step in growing and developing the suite of services that we offer listed companies, including greater support for investor relations teams and engagement with their shareholder registers. "The acquisition means that Computershare remains at the forefront of data-led services that assist companies in
PUMA Opens New Creative Hub Studio48 to Foster Excellence in Design and Elevate the Brand12.12.2024 10:00:00 CET | Press release
Sports company PUMA has opened Studio48, a new creative hub at its headquarters in Herzogenaurach, Germany, where its designers and creatives can come together to freely develop new ideas and create concepts for new performance and Sportstyle products as well as campaigns. Studio48 is part of the company’s strategy to create sustainable growth by elevating the brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212087978/en/ Sports company PUMA has opened Studio48, a new creative hub at its headquarters in Herzogenaurach, Germany, where its designers and creatives can come together to freely develop new ideas and create concepts for new performance and Sportstyle products as well as campaigns. (Photo: Business Wire) Spanning more than 500 square metres (5,300 square feet), Studio48 will feature a 3D printing facility, leather and textile sewing machines, a set up for printing and embroidering, a product testing area, a
Owkin unveils new insights into the opportunities and challenges for digital pathology and AI solutions in healthcare12.12.2024 10:00:00 CET | Press release
55% of pathologist and oncologist survey respondents globally are facing stress and burnout due to increasing complexity and high workloads More than a third highlight burdens they face are detrimental to patient care, and 77% agree that AI will help to cut waiting times for tests, and help with staffing The findings of this report underscore the urgent need to address the growing challenges faced by pathologists and oncologists Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare across the United States, United Kingdom, and France. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212654982/en/ Conducted in partnership with Censuswide, the research high
REPLY: Siemens and Roboverse Reply Automate Inspection Processes With Mobile Robots12.12.2024 10:00:00 CET | Press release
Roboverse Reply, the expert in robotics integration scenarios, has developed an end-to-end solution for AI-driven inspection processes in industrial environments together with Siemens, a leading technology company. Leveraging Siemens' "COMOS Mobile Worker", – an app used by organisations to plan and execute service technicians’ missions – technicians can now automate complex industrial maintenance tasks using autonomous mobile robots (AMRs) and drones from various manufacturers. This new function, that can be activated on request during software set up, enables users to significantly increase the life and operational reliability of their equipment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212221939/en/ Thanks to the integration of the Roboverse Reply Platform, the ‘COMOS Mobile Worker’ app from Siemens now also allows robots and drones from different manufacturers to be scheduled for autonomous inspection and mainte
SESIP Paves the Way for IoT Manufacturers to Meet New European Cybersecurity Rules12.12.2024 09:00:00 CET | Press release
GlobalPlatform’s SESIP methodology (EN 17927) offers a streamlined, cost-effective security framework for connected devices and components to conform to the EU’s new Cyber Resilience Act GlobalPlatform is calling for manufacturers of connected devices and components to adopt its “Security Evaluation Standard for IoT Platforms” (SESIP) methodology to demonstrate conformance with the European Union’s new Cyber Resilience Act (CRA), which comes into force this month. The CRA aims to strengthen and harmonize cybersecurity across the EU by creating a new legal framework for all products that connect to the internet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211681976/en/ (Graphic: Business Wire) The enactment of the CRA puts into place mandatory cybersecurity rules that span the entire lifecycle of a digital product sold in the EU. The CRA was published in the Official Journal of the European Union last month and becomes
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom